Home > Drug Search >
  • company_query: ACEA Biosciences
  •   > 
Drug Filter
Status:
NDA Filing (1) Phase Ⅲ (9) Phase Ⅱ (11) Phase Ⅰ (10) IND Filing (1)
Clinical Stage:
Pending (7) Active (19) Discontinued (6)
Indication:
Acute myeloid Leukemia (AML) (2) Alzheimer's disease (AD) (2) Atrial fibrillation (1) Bladder cancer (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Depression (1) Diabetic macular edema (1) Duchenne muscular dystrophy (DMD) (1) Gastric cancer (1) Gastroesophageal reflux disease (GERD) (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Hypercholesterolemia (2) Irritable bowel syndrome (IBS) (2) Lung cancer (2) Lymphoma (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (2) Ovarian cancer (2) Pancreatic cancer (1) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Soft tissue sarcoma (1) Solid tumours (6) Systemic lupus erythematosus (1) Type 2 diabetes (1) Head and neck cancer (2) Veno-occlusive disorders (1) Colorectal cancer (1) Systemic bacterial infections (1) Age-related macular degeneration (AMD) (1) Cervical carcinoma (2) Sarcoma (1) Sickle cell disease (1) Hematological cancer (2) Retinal vein occlusion (1) Proliferative diabetic retinopathy (1) Brain cancer (1) Skin disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top